Dr. Gülsen Mutluoglu SRL
Dr. Gülsen Mutluoglu reported total assets of 123,205 € at the end of the 2025 financial year (annual accounts filed with the NBB on 27 Apr 2026).
The score of Dr. Gülsen Mutluoglu shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr. Gülsen Mutluoglu's annual accounts
Filed annual accounts
- Year ended 30 Sep 2025filed on 27 Apr 2026
- Year ended 30 Sep 2024filed on 14 Apr 2025
Dr. Gülsen Mutluoglu's financial analysis
- Solvency79.0%sector median: 75.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr. Gülsen Mutluoglu
Dr. Gülsen Mutluoglu's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0805.221.744
- VAT number
- BE0805221744
- Peppol
- Registered · 0208:0805221744 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 29 Aug 2023
- Registered office
- 3404 Landen
- Latest accounts
- 2025 · filed on 27 Apr 2026
- Activity
- Diagnostic imaging services and medical laboratory activities (NACE 86910)
Dr. Gülsen Mutluoglu (SRL) has been based in Landen since 2023, active in: diagnostic imaging services and medical laboratory activities. For 2025, it reports a net profit of 44,298 € and equity of 97,346 €; its revenue is not published. Its solvency stands at 79.0%, above the median of its sector (75.0%).
Companies similar to Dr. Gülsen Mutluoglu
Companies in the same business, of comparable size and area, outside its group.
- Examen ET Prelevement Materiel Post Operatoire All other professional, scientific and technical activities n.e.c. Ath · balance sheet 148,982 €
- Docteur Vandenberghe Diagnostic imaging services and medical laboratory activities Soignies · balance sheet 119,685 €
- Drsl Beeldvorming Diagnostic imaging services and medical laboratory activities Bruges · balance sheet 151,980 €
- AM Analytica Diagnostic imaging services and medical laboratory activities Aalst · balance sheet 132,338 €
- Laboratoire Julie Hotton Diagnostic imaging services and medical laboratory activities Uccle · balance sheet 284,321 €
- LabCare Plus Diagnostic imaging services and medical laboratory activities Ghent · balance sheet 398,262 €
- Baptist Declerck Diagnostic imaging services and medical laboratory activities Hasselt · balance sheet 176,892 €
- Lahema Diagnostic imaging services and medical laboratory activities Meise · balance sheet 134,646 €
Frequently asked questions about Dr. Gülsen Mutluoglu
What is the revenue of Dr. Gülsen Mutluoglu?
Dr. Gülsen Mutluoglu files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr. Gülsen Mutluoglu?
In Belgium, the VAT number is the company number prefixed with BE: BE0805221744 for Dr. Gülsen Mutluoglu, if the company is VAT-registered. Its company number (CBE) is 0805.221.744.
Where is the registered office of Dr. Gülsen Mutluoglu?
According to the CBE register, the registered office of Dr. Gülsen Mutluoglu is in 3404 Landen.
What is the equity of Dr. Gülsen Mutluoglu?
At the close of the 2025 financial year, the equity of Dr. Gülsen Mutluoglu amounts to 97,346 €, a solvency of 79.0% of total assets.
Who manages Dr. Gülsen Mutluoglu?
The register lists 1 active mandates at Dr. Gülsen Mutluoglu. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dr. Gülsen Mutluoglu
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →